GPT and steatosis: The serum levels of ALT, AST, and alkaline phosphatase (ALP) were dramatically decreased upon NJT‐2 treatment (Figure S8C), and NJT‐2 significantly attenuated steatosis of the liver and muscle tissues (Figure S8D,E).